This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Stemcyte, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Richard Tonai: Innovator in HLA Typing Methods
Introduction
Richard Tonai is a notable inventor based in Valencia, CA (US). He has made significant contributions to the field of genetic typing, particularly in the area of HLA (Human Leukocyte Antigen) typing. His innovative methods have the potential to enhance tissue compatibility assessments, which are crucial in transplantation and immunology.
Latest Patents
Richard Tonai holds a patent for "High throughput methods of HLA typing." This patent describes a method for determining an HLA genotype of a subject. The process involves isolating template nucleic acid from the subject, amplifying it to generate sufficient product for each allele of at least one gene locus, hybridizing the nucleic acid with an immobilized array of capture oligonucleotides, and determining the specific capture oligonucleotide to which the template nucleic acid hybridizes. This method not only streamlines the HLA typing process but also provides additional techniques to eliminate or abbreviate steps, thereby improving efficiency.
Career Highlights
Richard Tonai is currently associated with Stemcyte, Inc., where he applies his expertise in genetic research and development. His work focuses on advancing methodologies that can significantly impact the field of tissue compatibility and transplantation.
Collaborations
One of his notable collaborators is Robert Chow, with whom he has worked on various projects related to HLA typing and genetic research.
Conclusion
Richard Tonai's contributions to HLA typing methods exemplify the importance of innovation in the field of genetics. His patented techniques are set to improve tissue compatibility assessments, which can have far-reaching implications in medical science.